RELATIONSHIP BETWEEN TUMOR SIZE AND THE CURABILITY OF METASTATIC PROSTATIC-CANCER BY SURGERY ALONE OR IN COMBINATION WITH ADJUVANT CHEMOTHERAPY

被引：52

作者：

HENRY, JM

ISAACS, JT

机构：

[1] JOHNS HOPKINS UNIV,SCH MED,DEPT UROL,BALTIMORE,MD 21205

[2] JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21205

来源：

关键词：

D O I：

10.1016/S0022-5347(17)42800-X

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1119 / 1123

页数：5

共 20 条

[1] CORBETT TH, 1978, CANCER TREAT REP, V62, P1471
[2] A NEW METHOD TO ASSESS METASTATIC POTENTIAL OF HUMAN-PROSTATE CANCER - RELATIVE NUCLEAR ROUNDNESS
DIAMOND, DA
BERRY, SJ
JEWETT, HJ
EGGLESTON, JC
COFFEY, DS
[J]. JOURNAL OF UROLOGY, 1982, 128 (04) : 729 - 734
[3] ELDER JS, 1983, CLIN ONCOLO, V2, P421
[4] ELDER JS, 1985, EORTC GENITOURINAR A, V2, P427
[5] LIMITATIONS OF MODEL SYSTEMS IN PROSTATIC CANCER
HANDELSMAN, H
[J]. ONCOLOGY, 1977, 34 (03) : 96 - 99
[6] SURGICAL ADJUVANT CHEMOTHERAPY OF METASTATIC MURINE OSTEO-SARCOMA
HIRAMOTO, RN
GHANTA, VK
[J]. INTERNATIONAL JOURNAL OF CANCER, 1980, 25 (03) : 393 - 397
[7] THE TIMING OF ANDROGEN ABLATION THERAPY AND OR CHEMOTHERAPY IN THE TREATMENT OF PROSTATIC-CANCER
ISAACS, JT
[J]. PROSTATE, 1984, 5 (01) : 1 - 17
[8] KADMON D, 1982, J UROLOGY, V127, P1238, DOI 10.1016/S0022-5347(17)54306-2
[9] LAZAN DW, 1982, CANCER RES, V42, P1390
[10] MCNEAL JE, 1986, LANCET, V1, P60